Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
IMAGION BIOSYSTEMS LIMITED (IBX)ASX AI Signals has generated 1 signal(s) for IBX during the last 90 days, indicating Moderate trading activity
Latest IBX Signals | |
| 24/04/2026 | SELL |
| 25/03/2026 | SELL |
IBX Share Price | |
| Current Price | $0.011 |
| 52 Week High | $0.049 |
| 52 Week Low: | $0.011 |
| Trading at (% of 52 Week High) | 22.45% |
Imagion Biosystems Limited (ASX: IBX) is a medical technology company focused on developing and commercializing diagnostic imaging products. The company specializes in using magnetic nanoparticle-based technology to improve the detection and treatment of cancer and other diseases. Their proprietary imaging platform aims to provide earlier and more accurate diagnosis.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
The SELL recommendation for IMAGION BIOSYSTEMS LIMITED (IBX) is supported by weak price performance and potential liquidity concerns at the current low price level. However, the confidence is moderated by limited publicly available financial data and market volatility typical of micro-cap stocks.
Emerging Growth
MIAMI, June 09, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 93rd Emerging Growth Conference on June 10 & 11, 2026.
The Emerging Growth Conference identifies companies in a wide range of growth sectors, with Imagion Biosystems Limited (ASX:IBX) shareholders have seen the share price descend 13% over the month. But in three years the returns have been great. In three years the stock price has launched 113% higher: a great result. After a run like that some may not be surprised to see prices moderate. The Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But while his Unless you borrow money to invest, the potential losses are limited. But if you pick the right stock, you can make a lot more than 100%. For example, the Imagion Biosystems Limited (ASX:IBX) share price has soared 102% return in just a single year. Shareholders are also celebrating an even better 37 Unless you borrow money to invest, the potential losses are limited. But if you pick the right stock, you can make a lot more than 100%. For example, the Imagion Biosystems Limited (ASX:IBX) share price has soared 102% return in just a single year. Shareholders are also celebrating an even better 37Latest IMAGION BIOSYSTEMS LIMITED(IBX) News
Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream
Imagion Biosystems' (ASX:IBX) investors will be pleased with their solid 125% return over the last three years
We're Hopeful That Imagion Biosystems (ASX:IBX) Will Use Its Cash Wisely
Is Imagion Biosystems' (ASX:IBX) 102% Share Price Increase Well Justified?
Is Imagion Biosystems' (ASX:IBX) 102% Share Price Increase Well Justified?
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial